ClassID:

20195

A61K31/04 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Nitro compounds

Recent Application in this class:
#301
20050228055
2005-10-13

Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof

#302
20050197300
2005-09-08

Microdose therapy

#303
20050171199
2005-08-04

Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents

#304
20050153940
2005-07-14

Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor

#305
20050148612
2005-07-07

Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria

#306
20050142103
2005-06-30

Mobilization of hematopoietic cells

#307
20050137191
2005-06-23

Nitrate esters and their use for mitigating cellular damage

#308
20050131064
2005-06-16

Therapeutic use of aerosolized nitrosylating agent in cystic fibrosis

#309
20050124691
2005-06-09

Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same

#310
20050074487
2005-04-07

Transdermal and topical administration of drugs using basic permeation enhancers

#311
20050043408
2005-02-24

Anti-glycation agents for preventing age- diabetes- and smoking-related complications

#312
20050042233
2005-02-24

Stabilized compositions containing an oxygen-labile active agent and a fungal extract

#313
20050037093
2005-02-17

Treatment of nail infections with no

#314
16725316
2023-09-19

Composition for treating wounds, dermatitis, inflammation, and irritation

#315
15873450
2018-10-30

Dihydropyrimidinone derivatives

#316
15682623
2019-01-22

2, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes

#317
14662497
2015-08-25

Capsule for sublingual and gastro-intestinal delivery of a liquid medication in a single volume limited dose

#318
13623690
2015-09-08

Method of stabilizing human eye tissue